[1]
E. O. Aiyere, J. Silverberg, S. Ali, and J. L. Parker, “Clinical Trial Risk in Type-2 Diabetes: Importance of Patient History”, J Pharm Pharm Sci, vol. 17, no. 3, pp. 393–400, Aug. 2014.